Information Provided By:
Fly News Breaks for May 9, 2018
AMED
May 9, 2018 | 09:17 EDT
Craig-Hallum analyst Kevin Ellich raised his price target for Amedisys to $82 from $69 after the company's Q1 results beat estimates driven by solid same-store home health and hospice volume growth, better than expected home health revenue per episode growth, and EBITDA margin expansion in each of its business segments. The analyst reiterates a Buy rating on the shares.
News For AMED From the Last 2 Days
There are no results for your query AMED